I'm sorry NixOS, I've failed you.

Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Halo: Edge of Dawn was just released this month and it’s a direct sequel to Halo Infinite. It’s ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...

For the fastest way to join Tom's Guide Club enter your email below. We'll send you a confirmation and sign you up to our newsletter to keep you updated on all the latest news. By submitting your ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

During the announcement trailer for Halo: Campaign Evolved, Halo Studios revealed that the split-screen campaign would be returning. This feature was one of the reasons why fans fell in love with the ...

Microsoft has announced plans to put Halo Infinite into maintenance mode later this month so developer Halo Studios can focus on working on multiple new Halo games. In a blog post, Halo Studios said ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...